Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain. (Q39691379)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

title

Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

0 references

Praveen K Kumar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

Trent Bjorndahl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

BeomSoo Han

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

Ali Yilmaz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

Eric Sherman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

Ray O Bahado-Singh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

David Mann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

Brian D Green

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

publication date

8 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

volume

1862

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1675-1684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

MetaboAnalyst: a web server for metabolomic data analysis and interpretation

13 March 2020

cites work

1 reference

25 December 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/NAR/GKP356

MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis

1 reference

25 December 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/NAR/GKS374

MetaboAnalyst 3.0--making metabolomics more meaningful

1 reference

25 December 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/NAR/GKV380

Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra

2 references

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1007/S10858-011-9480-X

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

2 references

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1007/S11306-012-0482-9

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Nutritional regulation of the insulin-like growth factors

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Mutant huntingtin enhances excitotoxic cell death.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Plasma phospholipids identify antecedent memory impairment in older adults.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Development of biomarkers for Huntington's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Natural History of Huntington Disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Computational approaches to metabolomics

2 references

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1007/978-1-60327-194-3_14

Metabolic profiling of Alzheimer's disease brains

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Early sympathetic hyperactivity in Huntington's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Decreased plasma alanine and isoleucine in Huntington's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Biomarkers for neurodegenerative diseases

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Selective induction of astrocytic gliosis generates deficits in neuronal inhibition

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Neuroscience. Regulating energy balance: the substrate strikes back

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Neurocognitive signs in prodromal Huntington disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Regulation of albumin mRNA in H4 rat hepatoma cells by the availability of essential amino acids.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Huntington's disease: the road to progress

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Metabolic Profiling of 3-Nitropropionic Acid Early-Stage Huntington’s Disease Rat Model Using Gas Chromatography Time-of-Flight Mass Spectrometry

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Planting alfalfa and cloning the Huntington's disease gene

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Accurate, fully-automated NMR spectral profiling for metabolomics

2 references

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0124219

Huntingtin aggregation and toxicity in Huntington's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Alterations in metabolic pathways and networks in Alzheimer's disease

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1016/J.BBADIS.2016.06.007

Identifiers

DOI

10.1016/J.BBADIS.2016.06.007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27288730 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference